Evidence map›Paper›PMID 40702648›Full record

ArticleClinical and translational medicine2025

Precision treatment in breast cancer: Leveraging genetic interactions.

Cai-Jin Lin, Xin Hu, Zhi-Ming Shao, Yi-Zhou Jiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cai-Jin LinDepartments of Breast Surgery, and Oncology, Key Laboratory of Breast Cancer, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0003-2990-3900
Xin HuPrecision Cancer Medical Center, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0002-8160-8362
Zhi-Ming ShaoDepartments of Breast Surgery, and Oncology, Key Laboratory of Breast Cancer, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
Yi-Zhou JiangDepartments of Breast Surgery, and Oncology, Key Laboratory of Breast Cancer, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

Funding

National Key Research and Development Project of China 2021YFF1201300National Natural Science Foundation of China 82272822National Natural Science Foundation of China 82341003National Natural Science Foundation of China 82373184National Natural Science Foundation of China 82403750National Natural Science Foundation of China 92159301Natural Science Foundation of Shanghai 22ZR1479200Natural Science Foundation of Shanghai 24ZR1412600Shanghai Key Laboratory of Breast Cancer 12DZ2260100SHDC Municipal Project for Developing Emerging and Frontier Technology in Shanghai Hospitals SHDC12021103
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40702648
PMCPMC12286894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.